Rachel Bashford-Rogers

Associate Professor at the University of Oxford, Co-Founder at Alchemab Therapeutics, and Co-Founder at Theraimmune

Associate Professor Rachael Bashford-Rogers at the University of Oxford. From adaptive immunity to clinical translation.

See also

Collegiate research university and one of the world's leading universities

Details last updated 17-Jan-2025

Rachel Bashford-Rogers is also referenced in the following:

Pioneering the next generation of antibody therapeutics for hard to treat diseases